Bioventus Inc. (BVS) stock

BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3033% below fair value

$10.86−0.13 (-1.18%)

Close on Nov 12, 2026Market cap $913.24MP/E 13.6Yield –

Bioventus EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Bioventus's EPS for the twelve months ending Sep 26, 2026 was $0.80, up 627.3% year over year. For fiscal 2025 it was $0.33. The highest annual figure on record is $0.33 in fiscal 2025.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$0.33	–
FY2024	Dec 31, 2024	-$0.56	–
FY2023	Dec 31, 2023	-$2.49	–
FY2022	Dec 31, 2022	-$2.59	–
FY2021	Dec 31, 2021	-$0.15	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 26, 2026	$0.08	+60.0%
Q2 FY2026	Jun 27, 2026	$0.47	+327.3%
Q1 FY2026	Mar 28, 2026	$0.04	–
Q4 FY2025	Dec 31, 2025	$0.21	–
Q3 FY2025	Sep 27, 2025	$0.05	–
Q2 FY2025	Jun 28, 2025	$0.11	–
Q1 FY2025	Mar 29, 2025	-$0.04	–
Q4 FY2024	Dec 31, 2024	-$0.01	–
Q3 FY2024	Sep 28, 2024	-$0.08	–
Q2 FY2024	Jun 29, 2024	-$0.40	–
Q1 FY2024	Mar 30, 2024	-$0.08	–
Q4 FY2023	Dec 31, 2023	-$0.10	–
Q3 FY2023	Sep 30, 2023	-$0.12	–
Q2 FY2023	Jul 1, 2023	-$0.06	–
Q1 FY2023	Apr 1, 2023	-$2.24	–
Q4 FY2022	Dec 31, 2022	-$0.52	–
Q3 FY2022	Oct 1, 2022	-$1.76	–
Q2 FY2022	Jul 2, 2022	-$0.11	–
Q1 FY2022	Apr 2, 2022	-$0.19	–
Q4 FY2021	Dec 31, 2021	-$0.01	–
Q3 FY2021	Oct 2, 2021	-$0.03	–
Q2 FY2021	Jul 3, 2021	-$0.10	–
Q1 FY2021	Apr 3, 2021	-$0.02	–